DarioHealth raises ~$18.8M via preferred stock; amends Avenue loan to extend maturity

DarioHealth Corp.

Closed private placement of 7,055 Series D and 11,750 Series D-1 preferred shares at $1,000 each, raising $18.8M.
Preferred stock convertible at $0.73/share, subject to stockholder approval and a 19.99% beneficial ownership blocker.
Amended Avenue loan: extended interest-only period by 6 months, conditional on revenue milestone; maturity extended to Nov 1, 2027.
Proforma cash balance of $34M as of Q3 2024; company targets profitability run-rate by end of 2025.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.